Published :
Tables : 57
Figures : 48
Category : Healthcare
No. of Pages : 220
Report Code : HC-1211
Acute kidney injury treatment market is expected to value over USD 1.8 billion by 2027 end and register a CAGR of over 6.4% during the forecast period 2020-2027. Increasing technological advancements, rising geriatric population, and increasing patient population remain the major factors stimulating the market growth. Technological advancements coupled with rising research and development activities are expected to expand the market size. Favorable initiatives launched by governments is expected to be the new acute kidney treatment injury treatment market trend. The market is bifurcated on the basis of type, end-user, and region. In terms of type, prerenal acute kidney injury is expected to hold a major market share. Rise in the geriatric population and increasing cases of heart failure have contributed towards the market growth. Additionally, low blood pressure and liver cirrhosis are also factors burgeoning market growth. In terms of end-user, hospitals control the growth of the market. The rapid expansion of hospitals in developed economies alongside favorable government initiatives is fueling the market growth as well. Based on regions, market size is expected to multiply in the North America region. The availability of efficient and developed healthcare infrastructure remains the key factor in escalating the market growth in the region. Increasing government approval is also spiking the market in the region. Rapidly increasing clinical pipeline and growing patient population are propelling the market proliferation in the growth. Asia-Pacific is also projected to be a lucrative region owing to the large penetration of prominent players and rapidly expanding the healthcare sector in the region. Increasing geriatric population in countries like Japan and China is expected to drive the market growth. Growing urbanization and rising critical care admissions are expected to positively influence the market. Prominent players of the market are AM-Pharma, Fresenius Medical Care AG & Co. KgaA., LG Chem., Asahi Kasei Medical, Angion Biomedia Corp., Baxter International, Inc., B.Braun Melsungen AG and Quark Pharmaceuticals, Inc. Acute Kidney Injury Treatment Market Segmentation: By Type Prerenal Acute Kidney Injury Intrinsic Renal Acute Kidney Injury Postrenal Acute Kidney Injury By Treatment Hemodialysis Continuous Renal Replacement Therapy Sustained low-efficiency dialysis Others By End-User Hospitals Ambulatory Surgical Centers Others By Region North America Europe Asia Pacific Latin America Middle East & Africa FutureWise Key Takeaways: Dialysis sector is expected to create a vast impact on the market as it's essential for critically ill patients Expansion of dialysis centers worldwide is expected to drive the market The governments of developing economies are setting up new dialysis centers, thus propelling the market growth Abu Dhabi Services Company and Abu Dhabi General Services Company announced to establish a state-of-the-art dialysis center in UAE. The centre would contain units of 65 kidney dialysis. As a result, increasing in number of dialysis centers offers immense opportunities for market growth Objectives of the Study: To provide with an exhaustive analysis on market by end-user, by type and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Increasing technological advancements, rising geriatric population, and increasing patient population remain the major factors stimulating the market growth. Technological advancements coupled with rising research and development activities are expected to expand the market size.
Favorable initiatives launched by governments is expected to be the new acute kidney treatment injury treatment market trend.
The market is bifurcated on the basis of type, end-user, and region. In terms of type, prerenal acute kidney injury is expected to hold a major market share. Rise in the geriatric population and increasing cases of heart failure have contributed towards the market growth. Additionally, low blood pressure and liver cirrhosis are also factors burgeoning market growth.
In terms of end-user, hospitals control the growth of the market. The rapid expansion of hospitals in developed economies alongside favorable government initiatives is fueling the market growth as well.
Based on regions, market size is expected to multiply in the North America region. The availability of efficient and developed healthcare infrastructure remains the key factor in escalating the market growth in the region. Increasing government approval is also spiking the market in the region. Rapidly increasing clinical pipeline and growing patient population are propelling the market proliferation in the growth.
Asia-Pacific is also projected to be a lucrative region owing to the large penetration of prominent players and rapidly expanding the healthcare sector in the region. Increasing geriatric population in countries like Japan and China is expected to drive the market growth. Growing urbanization and rising critical care admissions are expected to positively influence the market.
Prominent players of the market are AM-Pharma, Fresenius Medical Care AG & Co. KgaA., LG Chem., Asahi Kasei Medical, Angion Biomedia Corp., Baxter International, Inc., B.Braun Melsungen AG and Quark Pharmaceuticals, Inc.
Acute Kidney Injury Treatment Market Segmentation:
By Type
By Treatment
By End-User
By Region
FutureWise Key Takeaways:
Objectives of the Study:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Acute Kidney Injury Treatment Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Biomedical Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Acute Kidney Injury Treatment Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Acute Kidney Injury Treatment Market , By Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Prerenal Acute Kidney Injury 7.2. Postrenal Acute Kidney Injury 7.3. Intrinsic Renal Acute Kidney Injury 7.4. Others 8. Global Acute Kidney Injury Treatment Market , By Treatment Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Hemodialysis 8.2. Continuous Renal Replacement Therapy 8.3. Sustained low-efficiency dialysis 8.4. Others 9. Global Acute Kidney Injury Treatment Market , By End User Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Hospitals 9.2. Ambulatory Surgical Centers 9.3. Others 10. North America Acute Kidney Injury Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027 11. Latin America Acute Kidney Injury Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Argentina 11.3.3. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2020-2027 12. Europe Acute Kidney Injury Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9.Rest of Western Europe 13. Asia Pacific Acute Kidney Injury Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Acute Kidney Injury Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 15.1 ALLOKSYS LIFE SCIENCES B.V 15.1.1 Company Overview 15.1.2 Financial Overview 15.1.3 Strategic Overview 15.1.4.Product Overview 15.1.5.SWOT Analysis 15.2 AM PHARMA 15.2.1 Company Overview 15.2.2 Financial Overview 15.2.3 Strategic Overview 15.2.4.Product Overview 15.2.5.SWOT Analysis 15.3 FRESENIUS MEDICAL CARE 15.3.1 Company Overview 15.3.2 Financial Overview 15.3.3 Strategic Overview 15.3.4.Product Overview 15.3.5.SWOT Analysis 15.4 LG CHEM 15.4.1 Company Overview 15.4.2 Financial Overview 15.4.3 Strategic Overview 15.4.4.Product Overview 15.4.5.SWOT Analysis 15.5 ASAHI KASEI MEDICAL 15.5.1 Company Overview 15.5.2 Financial Overview 15.5.3 Strategic Overview 15.5.4.Product Overview 15.5.5.SWOT Analysis 15.6 ANGION BIOMEDIA CORP. 15.6.1 Company Overview 15.6.2 Financial Overview 15.6.3 Strategic Overview 15.6.4.Product Overview 15.6.5.SWOT Analysis 15.7 BAXTER INTERNATIONAL 15.7.1 Company Overview 15.7.2 Financial Overview 15.7.3 Strategic Overview 15.7.4.Product Overview 15.7.5.SWOT Analysis 15.8 B.BRAUN MELSUNGEN AG 15.8.1 Company Overview 15.8.2 Financial Overview 15.8.3 Strategic Overview 15.8.4.Product Overview 15.8.5.SWOT Analysis 15.9 QUARK PHARMACEUTICALS 15.9.1 Company Overview 15.9.2 Financial Overview 15.9.3 Strategic Overview 15.9.4.Product Overview 15.9.5.SWOT Analysis 15.10 STEALTH BIO THERAPEUTICS 15.10.1 Company Overview 15.10.2 Financial Overview 15.10.3 Strategic Overview 15.10.4.Product Overview 15.10.5.SWOT Analysis 16. FutureWise SME key takeaway points for Client
1. Market Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.3.2 Market Covered
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2. Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3. Executive Summary
3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Global Acute Kidney Injury Treatment Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Industry Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Technology Overview
4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances
5. Market Overview
5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Biomedical Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Acute Kidney Injury Treatment Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Acute Kidney Injury Treatment Market , By Type Historical Analysis and Forecast 2020-2027 (USD Million)
7.1. Prerenal Acute Kidney Injury
7.2. Postrenal Acute Kidney Injury
7.3. Intrinsic Renal Acute Kidney Injury
7.4. Others
8. Global Acute Kidney Injury Treatment Market , By Treatment Historical Analysis and Forecast 2020-2027 (USD Million)
8.1. Hemodialysis
8.2. Continuous Renal Replacement Therapy
8.3. Sustained low-efficiency dialysis
8.4. Others
9. Global Acute Kidney Injury Treatment Market , By End User Historical Analysis and Forecast 2020-2027 (USD Million)
9.1. Hospitals 9.2. Ambulatory Surgical Centers 9.3. Others
10. North America Acute Kidney Injury Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
10.1. Introduction
10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
10.2.1. U.S.A
10.2.2. Canada
10.2.3. Mexico
10.3. Market Size (USD Million) Forecast for North America 2020-2027
11. Latin America Acute Kidney Injury Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
11.1. Introduction
11.2. Regional Market Trends
11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
11.3.1. Brazil
11.3.2. Argentina
11.3.3. Rest of Latin America
11.4. Market Size (USD Million) Forecast for Latin America 2020-2027
12. Europe Acute Kidney Injury Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction
12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
12.2.1. Germany
12.2.2. U.K
12.2.3. France
12.2.4. Italy
12.2.5. Spain
12.2.6. Russia
12.2.7. Poland
12.2.8. Switzerland
12.2.9.Rest of Western Europe
13. Asia Pacific Acute Kidney Injury Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. Japan
13.2.2. China
13.2.3. Singapore
13.2.4. India
13.2.5. Australia and New Zealand
13.2.6. ASEAN
13.2.7. South Korea
13.2.8. Rest of Asia Pacific
13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
14. Middle East and Africa Acute Kidney Injury Treatment Market Analysis 2015–2019 and Forecast
2020–2027 (USD Million)
14.1. Introduction
14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
14.2.1. Saudi Arabia
14.2.2. UAE
14.2.3. South Africa
14.2.4. Egypt
14.3. Market Size (USD Million) Forecast for MEA 2020-2027
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
15.1 ALLOKSYS LIFE SCIENCES B.V
15.1.1 Company Overview
15.1.2 Financial Overview
15.1.3 Strategic Overview
15.1.4.Product Overview
15.1.5.SWOT Analysis
15.2 AM PHARMA
15.2.1 Company Overview
15.2.2 Financial Overview
15.2.3 Strategic Overview
15.2.4.Product Overview
15.2.5.SWOT Analysis
15.3 FRESENIUS MEDICAL CARE
15.3.1 Company Overview
15.3.2 Financial Overview
15.3.3 Strategic Overview
15.3.4.Product Overview
15.3.5.SWOT Analysis
15.4 LG CHEM
15.4.1 Company Overview
15.4.2 Financial Overview
15.4.3 Strategic Overview
15.4.4.Product Overview
15.4.5.SWOT Analysis
15.5 ASAHI KASEI MEDICAL
15.5.1 Company Overview
15.5.2 Financial Overview
15.5.3 Strategic Overview
15.5.4.Product Overview
15.5.5.SWOT Analysis
15.6 ANGION BIOMEDIA CORP.
15.6.1 Company Overview
15.6.2 Financial Overview
15.6.3 Strategic Overview
15.6.4.Product Overview
15.6.5.SWOT Analysis
15.7 BAXTER INTERNATIONAL
15.7.1 Company Overview
15.7.2 Financial Overview
15.7.3 Strategic Overview
15.7.4.Product Overview
15.7.5.SWOT Analysis
15.8 B.BRAUN MELSUNGEN AG
15.8.1 Company Overview
15.8.2 Financial Overview
15.8.3 Strategic Overview
15.8.4.Product Overview
15.8.5.SWOT Analysis
15.9 QUARK PHARMACEUTICALS
15.9.1 Company Overview
15.9.2 Financial Overview
15.9.3 Strategic Overview
15.9.4.Product Overview
15.9.5.SWOT Analysis
15.10 STEALTH BIO THERAPEUTICS
15.10.1 Company Overview
15.10.2 Financial Overview
15.10.3 Strategic Overview
15.10.4.Product Overview
15.10.5.SWOT Analysis
16. FutureWise SME key takeaway points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics